tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Revolution Medicines publishes zoldonrasib research in Science
PremiumThe FlyRevolution Medicines publishes zoldonrasib research in Science
18d ago
Revolution Medicines announces FDA BTD to elironrasib
Premium
The Fly
Revolution Medicines announces FDA BTD to elironrasib
19d ago
Revolution Medicines: Buy Rating Backed by Strategic Focus and Promising Clinical Developments in Precision Oncology
Premium
Ratings
Revolution Medicines: Buy Rating Backed by Strategic Focus and Promising Clinical Developments in Precision Oncology
27d ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
1M ago
Promising Prospects for Revolution Medicines’ Daraxonrasib in Pancreatic Cancer Treatment
Premium
Ratings
Promising Prospects for Revolution Medicines’ Daraxonrasib in Pancreatic Cancer Treatment
1M ago
Strategic Collaboration and Promising Trial Results Drive Buy Rating for Revolution Medicines
Premium
Ratings
Strategic Collaboration and Promising Trial Results Drive Buy Rating for Revolution Medicines
1M ago
Revolution Medicines: Strategic Partnership and Promising Trials Drive Buy Rating
PremiumRatingsRevolution Medicines: Strategic Partnership and Promising Trials Drive Buy Rating
2M ago
Strategic Partnership with Royalty Pharma Enhances Revolution Medicines’ Financial Flexibility and Growth Potential
Premium
Ratings
Strategic Partnership with Royalty Pharma Enhances Revolution Medicines’ Financial Flexibility and Growth Potential
2M ago
Revolution Medicines Secures $2 Billion Funding Agreement
Premium
Company Announcements
Revolution Medicines Secures $2 Billion Funding Agreement
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100